Syphilis serology in human immunodeficiency virus infection: Evidence for false-negative fluorescent treponemal testing

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1397-1400

  Erbelding, Emily J ^a   Vlahov, David ^b   Nelson, Kenrad E ^b   Rompalo, Anne M ^b   Cohn, Sylvia ^b   Sanchez, Pablo ^b   Quinn, Thomas C ^b   Brathwaite, Wayne ^b   Thomas, David L ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; REAGINIC ANTIBODY;

ALGORITHM; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; FLUORESCENT TREPONEMA ANTIBODY TEST; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAGIN TEST; SYPHILIS; SYPHILIS SEROLOGY; TREPONEMA PALLIDUM;

EID: 0030840335     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517330     Document Type: Article

References (15)

1. Musher D. Biology of T. pallidum. In: Holmes KK, Mardh P, Sparling PF, et al., eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990:205-11.
2. Kaufman RE, Weiss S, Moore JD, Falcone V, Weisner PJ. Biological false positive serological tests for syphilis among drug addicts. Br J Vener Dis 1974;50:350-3.
3. Rompalo AM, Cannon RO, Quinn TC, Hook EW III. The association of biologic false-positive serologic tests for syphilis with human immunodeficiency virus infection. J Infect Dis 1992;165:1124-6.
4. Thomas DL, Rompalo AM, Zenilman J, Hoover D, Hook EW III, Quinn TC. Association of hepatitis C infection with false-positive tests for syphilis. J Infect Dis 1994;170:1579-81.
5. Glatt AE, Stoffer HR, Forlenza S, Altieri RH: High-liter positive nontreponemal tests with negative specific treponemal serology in patients with HIV infection and/or intravenous substance use. J Acquir Immune Defic Syndr 1991;4:861-4.
6. Hicks CB, Benson PM, Lupton I, Tramont EC. Seronegative secondary syphilis in a patient with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med 1987;107:492-5. (Erratum in Ann Intern Med 1987;107:946.)
7. Tikjob G, Russel M, Petersen CS, Gerstoft J, Kobayasi T. Seronegative secondary syphilis in a patient with AIDS: identification of T. pallidum in biopsy specimen. J Am Acad Dermatol 1988;18:423-8.
8. Radolf JD, Kaplan RP. Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 1988;18:423-8.
9. Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type-1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990;132:847-56.
10. Nelson KE, Vlahov D, Cohn S, et al. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus. J Infect Dis 1991;164:457-63.
11. Weigel LM, Brandt ME, Norgard MV. Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum. Infect Immun 1992;60:1568-76.
12. Akins DR, Purcell BK, Mitra MM, Norgard MV, Radolf JD. Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity. Infect Immun 1993;61:1202-10.
13. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1643-8.
14. Caiaffa WT, Graham NMH, Galai N, Rizzo RT, Nelson KE, Vlahov D. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med 1995;155:2111-7.
15. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines: syphilis. MMWR Morb Mortal Wkly Rep 1993;42(RR-14):27-40.